San Mateo, CA, United States of America

Barton W Phillips

This inventor holds 46 USPTO granted patents and 10 published patent applications, plus 9 CIPO patents and 27 EPO patents, primarily in Cancer Therapeutics. Top assignees: Gilead Sciences, Inc., Bayer Healthcare LLC, Bayer Pharmaceuticals Corporation. Active years: 2006-2026.

USPTO Granted Patents = 46 

% Patents Active = 63.0

 

 

Average Co-Inventor Count = 11.6

ph-index = 5

Forward Citations = 107(Granted Patents)


Location History:

  • Hamden, CT (US) (2009)
  • New Haven, CT (US) (2006 - 2014)
  • San Mateo, CA (US) (2011 - 2024)

Company Filing History:


Years Active: 2006-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
PD-1 Inhibitors
LPA Receptor Antagonists
PI3K Inhibitors
Cancer Treatment
Triazole Compounds
Hepatitis C Inhibitors
Aurora Kinase
Hyper-Proliferative Disorders
Angiogenesis
Bicyclic Urea Derivatives
Antiviral Compounds
Benzofuran Derivatives
46 patents (USPTO):Explore Patents

Title: Barton W Phillips: Pioneering Inventor from San Mateo

Introduction: Barton W Phillips is a renowned inventor based in San Mateo, California, known for his groundbreaking contributions to various industries.

Latest Patents: Barton W Phillips holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of innovative ideas.

Career Highlights: With a career spanning over two decades, Barton W Phillips has worked with leading companies to develop cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Barton W Phillips has collaborated with top researchers, engineers, and designers to bring his inventions to life, fostering a culture of innovation and creativity.

Conclusion: Barton W Phillips continues to inspire the next generation of inventors with his visionary ideas and relentless pursuit of excellence in the world of innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…